Clinical Trial: A Study of BGM0504 in Chinese Patients With Type 2 Diabetes

U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06974825) titled 'A Study of BGM0504 in Chinese Patients With Type 2 Diabetes' on May 14.

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of BGM0504 in Chinese patients with Type 2 Diabetes.

Study Start Date: Aug. 30, 2023

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes

Intervention: DRUG: BGM0504 Administered SC

5 milligrams (mg) BGM0504 administered subcutaneously (SC) once a week.

DRUG: BGM0504 Administered SC

Experimental: 10 mg BGM0504 10 mg BGM0504 administered SC once a week.

DRUG: BGM0504 Administered SC

Experimental: 15 mg BGM0504 15 mg BGM0504 administered SC once a week.

DRUG: Semaglutide Ad...